×
  • Catégorie
  • Type
  • Advanced

L’importance des questions de genre dans le programme pour la vaccination à l’horizon 2030

Directives de Gavi sur la riposte aux obstacles sexospécifiques au maintien, à la restauration et au renforcement de la vaccination dans le contexte de la COVID-19

Health care waste management in immunization programs: Guidance for proposal planning - synthesis document

Health care waste management in immunization programs: Guidance for proposal planning

Health care waste management maturity model

GUIDE PAYS POUR LA SELECTION DE SIGL (Systèmes D’Information pour la Gestion Logistique)

Country Guidance on Selecting LMIS

Finding the Signal through the Noise

Guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment

Gavi Guidance to Address Gender-Related Barriers to Maintain, Restore and Strengthen Immunisation in the Context of COVID-19

COVAX: The vaccines pillar of the access to COVID-19 tools (ACT) accelerator structure and principles

Training on Pfizer‒BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran) - Updated 5 October 2021

Pneumococcal Conjugate Vaccine (PCV) 4-dose vial presentations - Frequently Asked Questions (FAQs)

WHO e-scholar course on triangulation: Video recordings of webinars

Data Analysis Guidance

Webinar 2: Data for Programme Strengthening at National Level (WHO e-scholar Level 2 Course)

New guidance for managing health care waste produced by your immunisation program: GAVI presentation

Target Software Standards for Vaccine Supply Chain Information Systems

Vaccine Innovation Lexicon

Keeping children healthy: The Vaccine Alliance Progress Report 2015